Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Drug-Eluting Stent Study: How Innovation Changes Care Patterns, Costs

This article was originally published in The Pink Sheet Daily

Executive Summary

Drug-eluting stents added $1.57 billion in annual Medicare costs in their first four years on the U.S. market, with the largest increases occurring among patients with stable coronary disease, according to observational research published April 25.

You may also be interested in...

Senate Finance Committee Examines Improper Cardiac Stent Implants

The Senate Finance Committee signaled enhanced scrutiny into unnecessary use of stents and other implantable devices in a report released Dec. 6.

COURAGE Suggests Stents Do Not Benefit Stable Coronary Disease Patients

Results of the highly anticipated COURAGE trial challenge the widespread assumption that stents improve outcomes in patients with stable coronary disease, but several observers believe the findings' impact on the stent market will be modest

Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind

Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts